Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
02/17/2023 | 259.71% | EF Hutton | → $10 | Assumes | → Buy |
12/29/2022 | 475.54% | EF Hutton | $17 → $16 | Maintains | Buy |
04/07/2022 | 511.51% | EF Hutton | → $17 | Initiates Coverage On | → Buy |
01/13/2020 | 547.48% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
What is the target price for CEL-SCI (CVM)?
The latest price target for CEL-SCI (AMEX: CVM) was reported by EF Hutton on February 17, 2023. The analyst firm set a price target for $10.00 expecting CVM to rise to within 12 months (a possible 259.71% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CEL-SCI (CVM)?
The latest analyst rating for CEL-SCI (AMEX: CVM) was provided by EF Hutton, and CEL-SCI their buy rating.
When is the next analyst rating going to be posted or updated for CEL-SCI (CVM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CEL-SCI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CEL-SCI was filed on February 17, 2023 so you should expect the next rating to be made available sometime around February 17, 2024.
Is the Analyst Rating CEL-SCI (CVM) correct?
While ratings are subjective and will change, the latest CEL-SCI (CVM) rating was a with a price target of $0.00 to $10.00. The current price CEL-SCI (CVM) is trading at is $2.78, which is within the analyst's predicted range.